文献
(701～800)701. Hamaguchi S, Yokoshiki H, Kinugawa S, et al. Japanese Cardiac Registry of Heart Failure in Cardiology Investigators. Effects of atrial
fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan: a report from the Japanese Cardiac Registry of Heart
Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 2084-2090. PMID: 19755750
702. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;
261: 884-888. PMID: 2913385
703. Gargani L, Frassi F, Soldati G, et al. Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison
with natriuretic peptides. Eur J Heart Fail 2008; 10: 70-77. PMID: 18077210
704. Al Deeb M, Barbic S, Featherstone R, et al. Point-of-care ultrasonography for the diagnosis of acute cardiogenic pulmonary edema in
patients presenting with acute dyspnea: a systematic review and meta- analysis. Acad Emerg Med 2014; 21: 843-852. PMID: 25176151
705. Mebazaa A, Tolppanen H, Mueller C, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive
Care Med 2016; 42: 147-163. PMID: 26370690
706. 日本循環器学会．急性および慢性心筋炎の診断・治療に関するガイドライン（2009年改訂版）．
706a.日本循環器学会．肺血栓塞栓症および深部静脈血栓症の診断、治療、予防に関するガイドライン（2009年改訂版）．
707. Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur J Heart Fail 1999; 1: 251-257. PMID: 10935671
708. Mentz RJ, Metra M, Cotter G, et al. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the
PROTECT trial. Eur J Heart Fail 2015; 17: 697-706. PMID: 26083764
709. Prins KW, Neill JM, Tyler JO, et al. Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review
and Meta-Analysis. JACC Heart Fail 2015; 3: 647-653. PMID:26251094
710. Kajimoto K, Sato N, Sakata Y, et al. Acute Decompensated Heart Failure Syndromes (ATTEND) investigators. Relationship between
systolic blood pressure and preserved or reduced ejection fraction at admission in patients hospitalized for acute heart failure syndromes.
Int J Cardiol 2013; 168: 4790-4795. PMID: 23962780
711. Ellingsrud C, Agewall S. Morphine in the treatment of acute pulmonary oedema--Why? Int J Cardiol 2016; 202: 870-873. PMID:
26476045
712. Bristow MR, Shakar SF, Linseman JV, et al. Inotropes and beta- blockers: is there a need for new guidelines? J Card Fail 2001; 7:
8-12. PMID: 11605160
713. Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and
organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 2011; 39: 450-455. PMID: 21037469
714. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic
balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of
a randomised, open-label trial. Lancet 2013; 382: 1638-1645. PMID: 24011548
715. 日本循環器学会．ST上昇型急性心筋梗塞の診療に関するガイドライン（2013年改訂版）．
716. 日本循環器学会．非ST上昇型急性冠症候群の診療に関するガイドライン（2012年改訂版）．
717. Ambrosy AP, Pang PS, Khan S, et al. EVEREST Trial Investigators. Clinical course and predictive value of congestion during
hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the
EVEREST trial. Eur Heart J 2013; 34: 835-843. PMID: 23293303
718. Vismara LA, Leaman DM, Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976;
54: 335-337. PMID: 939031
719. Iakobishvili Z, Cohen E, Garty M, et al. Heart Failure Survey in Isarel (HFSIS) Investigators. Use of intravenous morphine for acute
decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care 2011; 13: 76-80. PMID: 21627393
720. Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis.
Emerg Med J 2008; 25: 205-209. PMID: 18356349
721. Cotter G, Metzkor E, Kaluski E, et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose
furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998; 351: 389-393. PMID: 9482291
722. Matsue Y, Damman K, Voors AA, et al. Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
J Am Coll Cardiol 2017; 69: 3042-3051. PMID: 28641794
723. Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001; 96: 132-143. PMID: 11805380
724. Dormans TP, van Meyel JJ, Gerlag PG, et al. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus
continuous infusion. J Am Coll Cardiol 1996; 28: 376-382. PMID: 8800113
725. Felker GM, Lee KL, Bull DA, et al. NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute
decompensated heart failure. N Engl J Med 2011; 364: 797-805. PMID: 21366472
726. Takei M, Kohsaka S, Shiraishi Y, et al. West Tokyo Heart Failure Registry Investigators. Effect of estimated plasma volume reduction
on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction. Circ Heart Fail 2015; 8:
527-532. PMID: 25737498
727. Matsue Y, Suzuki M, Torii S, et al. Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal
dysfunction. Int J Cardiol 2016; 221: 188-193. PMID: 27404673
728. Konstam MA, Kiernan M, Chandler A, et al. SECRET of CHF Investigators, Coordinators, and Committee Members. Short-Term Effects
of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol 2017; 69: 1409-1419. PMID: 28302292
729. Felker GM, Mentz RJ, Cole RT, et al. Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure. J Am Coll
Cardiol 2017; 69: 1399-1406. PMID: 27654854
730. Matsue Y, Suzuki M, Seya M, et al. Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart
failure in high-risk population. J Cardiol 2013; 61: 169-174. PMID: 23159210
731. Hanatani A, Shibata A, Kitada R, et al. Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving
renal dysfunction in patients with congestive heart failure and renal dysfunction. Heart Vessels 2017; 32: 287-294. PMID: 27385022
732. Watanabe K, Dohi K, Sugimoto T, et al. Short-term effects of lowdose tolvaptan on hemodynamic parameters in patients with chronic
heart failure. J Cardiol 2012; 60: 462-469. PMID: 23068288
733. Tsutamoto T, Kinoshita M, Nakae I, et al. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Am Heart J 1994; 127: 866-873. PMID: 8154425
734. Tsutamoto T, Kinoshita M, Hisanaga T, et al. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of
nicorandil and nitroglycerin in patients with congestive heart failure. Am J Cardiol 1995; 75: 1162-1165. PMID: 7762505
735. Tanaka K, Kato K, Takano T, et al. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute
decompensated heart failure. J Cardiol 2010; 56: 291-299. PMID: 20709498
736. Hata N, Seino Y, Tsutamoto T, et al. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic
heart failure: the PROTECT multicenter randomized controlled study. Circ J 2008; 72: 1787-1793. PMID: 18812677
737. Sezai A, Hata M, Niino T, et al. Continuous low-dose infusion of humn atrial natriuretic peptide in patients with left ventricular dysfunction
undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion
Therapy during cardiac surgery) for left ventricular dysfunction. J Am Coll Cardiol 2010; 55: 1844-1851. PMID: 20413036
738. Matsue Y, Kagiyama N, Yoshida K, et al. Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A
Propensity Score-Matched Analysis. J Card Fail 2015; 21: 859-864.PMID: 25999241
739. Mizuno A, Iguchi H, Sawada Y, et al. The impact of carperitide usage on the cost of hospitalization and outcome in patients with acute
heart failure: High value care vs. low value care campaign in Japan. Int J Cardiol 2017; 241: 243-248. PMID: 28476514
740. Suwa M, Seino Y, Nomachi Y, et al. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in
the ‘real world’ of therapy. Circ J 2005; 69: 283-290. PMID:15731532
741. Abraham WT, Adams KF, Fonarow GC, et al. ADHERE Scientific Advisory Committee and Investigators. In-hospital mortality in patients
with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated
Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46: 57-64. PMID: 15992636
742. ドブタミン研究会．ポンプ不全に対するドブタミン，ドパミンの 薬剤効果の比較―多施設共同研究の集計．最新医学 1984; 39:1657-1672.
743. Spear GS. Eosinophilic explant carditis with eosinophilia: ?Hypersensitivity to dobutamine infusion. J Heart Lung Transplant 1995;
14: 755-760. PMID: 7578186
744. O’Connor CM, Gattis WA, Uretsky BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in
patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999; 138: 78-86.
PMID: 10385768
745. Giamouzis G, Butler J, Starling RC, et al. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of
the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial. J Card Fail 2010; 16: 922-930. PMID: 21111980
746. Bellomo R, Chapman M, Finfer S, et al. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Low-dose
dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet 2000; 356: 2139-2143. PMID:
11191541
747. Chen HH, Anstrom KJ, Givertz MM, et al. NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide
in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 2013; 310: 2533-2543. PMID:
24247300
748. Triposkiadis FK, Butler J, Karayannis G, et al. Efficacy and safety of high dose versus low dose furosemide with or without dopamine
infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Int J Cardiol 2014; 172: 115-121. PMID:
24485633
749. Ribner HS, Plucinski DA, Hsieh AM, et al. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to
dilated cardiomyopathy: a hemodynamic-hormonal study. Am J Cardiol 1985; 56: 896-904. PMID: 3904388
750. Seino Y, Momomura S, Takano T, et al. Japan Intravenous Milrinone Investigators. Multicenter, double-blind study of intravenous milrinone
for patients with acute heart failure in Japan. Crit Care Med 1996; 24: 1490-1497. PMID: 8797620
751. Lowes BD, Tsvetkova T, Eichhorn EJ, et al. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J
Cardiol 2001; 81: 141-149. PMID: 11744130
752. Costanzo MR, Johannes RS, Pine M, et al. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies
in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely
Decompensated Heart Failure National Registry (ADHERE) database. Am Heart J 2007; 154: 267-277. PMID: 17643575
753. Cuffe MS, Califf RM, Adams KF, et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart
Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized
controlled trial. JAMA 2002; 287: 1541-1547. PMID: 11911756
754. Guyton AC, Lindsey AW. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of
pulmonary edema. Circ Res 1959; 7: 649-657. PMID: 13663218
755. Masip J, Betbesé AJ, Páez J, et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic
pulmonary oedema: a randomised trial. Lancet 2000; 356: 2126- 2132. PMID: 11191538
756. Bersten AD, Holt AW, Vedig AE, et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure
delivered by face mask. N Engl J Med 1991; 325: 1825-1830. PMID: 1961221
757. Takeda S, Nejima J, Takano T, et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute
myocardial infarction. Jpn Circ J 1998; 62: 553-558. PMID: 9741730
758. Vital FM, Saconato H, Ladeira MT, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary
edema. Cochrane Database Syst Rev 2008: CD005351. pub2. PMID: 18646124
759. Johnson A, Mackway-Jones K. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary.
Frusemide or nitrates in acute left ventricular failure. Emerg Med J 2001; 18: 59-60. PMID: 11310465
760. Brochard L. Mechanical ventilation: invasive versus noninvasive. Eur Respir J Suppl 2003; 47: 31s-37s. PMID: 14621115
761. Takano T, Endo T, Tanaka K, et al. Effects of positive end-expiratory pressure ventilation and extracorporeal ultrafiltration method in pa
PMID: 3528548
762. MacIntyre NR, Cook DJ, Ely EW, et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task
force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College
of Critical Care Medicine. Chest 2001; 120: 375S-395S. PMID: 11742959
763. Hernández G, Vaquero C, González P, et al. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on
Reintubation in Low-Risk Patients: A Randomized Clinical Trial. JAMA 2016; 315: 1354-1361. PMID: 26975498
764. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and
Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task
Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll
Cardiol 2009; 53: e1-e90. PMID: 19358937
765. Asaba H, Bergström J, Fürst P, et al. Treatment of Diuretic-Resistant Fluid Retention with Ultrafiltration. Act Med Scan 1978; 204: 145-
149.
766. Costanzo MR, Guglin ME, Saltzberg MT, et al. UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients
hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683. PMID: 17291932
767. Bart BA, Goldsmith SR, Lee KL, et al. Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with
cardiorenal syndrome. N Engl J Med 2012; 367: 2296-2304. PMID: 23131078
768. Little WC, Freeman GL. Pericardial disease. Circulation 2006; 113: 1622-1632. PMID: 16567581
769. Khandaker MH, Espinosa RE, Nishimura RA, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc 2010; 85: 572-593.
PMID: 20511488
770. Leimgruber PP, Klopfenstein HS, Wann LS, et al. The hemodynamic derangement associated with right ventricular diastolic collapse in
cardiac tamponade: an experimental echocardiographic study. Circulation 1983; 68: 612-620. PMID: 6872172
771. Appleton CP, Hatle LK, Popp RL. Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied
by Doppler echocardiography. J Am Coll Cardiol 1988; 11: 1020- 1030. PMID: 3281990
772. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:
a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to
Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of
Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic
Surgeons. J Am Coll Cardiol 2006; 48: e1-148. PMID: 16875962
773. Nienaber CA, von Kodolitsch Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by noninvasive imaging procedures. N Engl
J Med 1993; 328: 1-9. PMID: 8416265
774. Smith MD, Cassidy JM, Souther S, et al. Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. N Engl J
Med 1995; 332: 356-362. PMID: 7823997
775. Picard MH, Davidoff R, Sleeper LA, et al. SHOCK Trial. SHould we emergently revascularize Occluded Coronaries for cardiogenic
shocK. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 2003; 107:
279-284. PMID: 12538428
776. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With
ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice
Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family
Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With
ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008; 117: 296-329. PMID:18071078
777. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999
Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110: e340-e437. PMID: 15466654
778. Pappas PJ, Cernaianu AC, Baldino WA, et al. Ventricular free-wall rupture after myocardial infarction. Treatment and outcome. Chest
1991; 99: 892-895. PMID: 2009791
779. Crenshaw BS, Granger CB, Birnbaum Y, et al. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries)
Trial Investigators. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute
myocardial infarction. Circulation 2000; 101: 27-32. PMID: 10618300
780. Thompson CR, Buller CE, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial
infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?
J Am Coll Cardiol 2000; 36: 1104-1109. PMID: 10985712
781. Fasol R, Lakew F, Wetter S. Mitral repair in patients with a ruptured papillary muscle. Am Heart J 2000; 139: 549-554. PMID: 10689272
782. 玉城雄也，小西治美，堀池聖子，他．重症心不全患者に対する心臓集中治療室での早期心臓リハビリテーションプログラムの導入．
心臓リハビリテーション 2016; 22: 71-76.
783. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left
ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998; 116: 50-59. PMID: 9671897
784. Jones RH, Velazquez EJ, Michler RE, et al. STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical
ventricular reconstruction. N Engl J Med 2009; 360: 1705-1717. PMID: 19329820
785. Kainuma S, Taniguchi K, Toda K, et al. Restrictive mitral annuloplasty with or without surgical ventricular reconstruction in ischaemic
cardiomyopathy: impacts on neurohormonal activation, reverse left ventricular remodelling and survival. Eur J Heart Fail 2014; 16: 189-
200. PMID: 24464828
786. Wakasa S, Matsui Y, Isomura T, et al. Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic
cardiomyopathy: results of a Japanese multicenter study. J Thorac Cardiovasc Surg 2014; 147: 1868-1874, 1874.e1-e2. PMID: 23968870
787. 日本循環器学会．循環器病ガイドシリーズ2014年度版．先天性心疾患、心臓大血管の構造的疾患（structural heart disease）に対するカテーテル
788. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the
European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the
European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29: 1463-1470. PMID: 18474941
789. Rosenhek R, Iung B, Tornos P, et al. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in
patients with valvular heart disease. Eur Heart J 2012; 33: 822-828, 828a, 828b. PMID: 21406443
790. Roques F, Nashef SA, Michel P. EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s:
lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001; 10: 572-577; discussion 577-578. PMID: 11603595
791. Ferguson TB Jr, Dziuban SW, Edwards FH, et al. The STS National Database: current changes and challenges for the new millennium.
Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg 2000; 69:
680-691. PMID: 10750744
792. Svensson LG, Adams DH, Bonow RO, et al. Aortic valve and ascending aorta guidelines for management and quality measures: executive
summary. Ann Thorac Surg 2013; 95: 1491-1505. PMID: 23291103 793. Dewey TM, Brown D, Ryan WH, et al. Reliability of risk
algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc
Surg 2008; 135: 180-187. PMID: 18179938
794. Lee DH, Buth KJ, Martin BJ, et al. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery.
Circulation 2010; 121: 973-978. PMID: 20159833
795. Thourani VH, Chowdhury R, Gunter RL, et al. The impact of specific preoperative organ dysfunction in patients undergoing aortic valve
replacement. Ann Thorac Surg 2013; 95: 838-845. PMID: 23245447
796. Leon MB, Smith CR, Mack M, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients
who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607. PMID: 20961243
797. Kapadia SR, Leon MB, Makkar RR, et al. PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement
compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;
385: 2485-2491. PMID: 25788231
798. Reardon MJ, Adams DH, Kleiman NS, et al. 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic
Valve Replacement. J Am Coll Cardiol 2015; 66: 113-121. PMID:26055947
799. Adams DH, Popma JJ, Reardon MJ, et al. U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-
expanding prosthesis. N Engl J Med 2014; 370: 1790-1798. PMID: 24678937
800. Smith CR, Leon MB, Mack MJ, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk
patients. N Engl J Med 2011; 364: 2187-2198. PMID: 21639811
急性･慢性心不全診療ガイドライン（2017年改訂版）
Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure
（JCS 2017/JHFS 2017）